These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The importance of serotonin-dopamine interactions in the action of clozapine. Meltzer HY Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125 [TBL] [Abstract][Full Text] [Related]
24. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Green AI; Zimmet SV; Strous RD; Schildkraut JJ Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435 [TBL] [Abstract][Full Text] [Related]
25. 5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system. Kilpatrick GJ; Hagan RM; Gale JD Behav Brain Res; 1996; 73(1-2):11-3. PubMed ID: 8788470 [TBL] [Abstract][Full Text] [Related]
26. Serotonin-dopamine interaction and its relevance to schizophrenia. Kapur S; Remington G Am J Psychiatry; 1996 Apr; 153(4):466-76. PubMed ID: 8599393 [TBL] [Abstract][Full Text] [Related]
27. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. Kuroki T; Meltzer HY; Ichikawa J J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588 [TBL] [Abstract][Full Text] [Related]
28. Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. Watling KJ; Beer MS; Stanton JA; Newberry NR Eur J Pharmacol; 1990 Jul; 182(3):465-72. PubMed ID: 1977590 [TBL] [Abstract][Full Text] [Related]
29. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism. Ichikawa J; Li Z; Dai J; Meltzer HY Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705 [TBL] [Abstract][Full Text] [Related]
30. The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems. Tricklebank MD Behav Brain Res; 1996; 73(1-2):15-7. PubMed ID: 8788471 [TBL] [Abstract][Full Text] [Related]
31. The mechanism of action of novel antipsychotic drugs. Meltzer HY Schizophr Bull; 1991; 17(2):263-87. PubMed ID: 1679253 [TBL] [Abstract][Full Text] [Related]
32. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate. Jardemark KE; Liang X; Arvanov V; Wang RY Neuroscience; 2000; 100(1):1-9. PubMed ID: 10996453 [TBL] [Abstract][Full Text] [Related]
33. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro. Arvanov VL; Wang RY Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117 [TBL] [Abstract][Full Text] [Related]
34. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine. Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798 [TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
36. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo. Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552 [TBL] [Abstract][Full Text] [Related]
37. The role of serotonin in antipsychotic drug action. Meltzer HY Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):106S-115S. PubMed ID: 10432496 [TBL] [Abstract][Full Text] [Related]
38. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398 [TBL] [Abstract][Full Text] [Related]
39. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244 [TBL] [Abstract][Full Text] [Related]